{
    "name": "oxytocin",
    "comment": "Rx",
    "other_names": [
        "Pitocin"
    ],
    "classes": [
        "Oxytocic Agents"
    ],
    "source": "https://reference.medscape.com/drug/pitocin-oxytocin-343132",
    "pregnancy": {
        "common": [
            "Oxytocin injection is used in pregnancy for induction of labor in patients with a medical indication for initiation of labor; stimulation or reinforcement of labor, as in selected cases of uterine inertia; and adjunctive therapy in management of incomplete or inevitable abortion; there are no known indications for use of this drug in first and second trimester of pregnancy other than in relation to spontaneous or induced abortion; based on wide experience with this drug and its chemical structure and pharmacological properties, it would not be expected to present a risk of fetal abnormalities when used as indicated"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Not known whether this drug is excreted in human milk; because many drugs are excreted in human milk, exercise caution when oxytocin is administered to nursing woman",
            "Developmental and health benefits of breastfeeding should be considered along with motherâ€™s clinical need for oxytocin Injection and any potential adverse effects on breastfed child from oxytocin Injection or from underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Elective induction of labor is defined as the initiation of labor in a pregnant individual who has no medical indications for induction.",
                "Because the available data are inadequate to evaluate the benefits-to-risks onsiderations, oxytocin is not indicated for elective induction of labor."
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Significant cephalopelvic disproportion",
                "Unfavorable fetal positions or presentations, eg, transverse lies,which are undeliverable without conversion prior to delivery",
                "Obstetric emergencies that favor surgery",
                "Fetal distress where delivery is not imminent",
                "Where adequate uterine activity fails to achieve satisfactory progress",
                "Hyperactive or hypertonic uterus",
                "Contraindicated vaginal delivery, eg, invasive cervical carcinoma, active herpes genitalis, total placenta previa, vasa previa, & cord presentation or prolapse of cord",
                "Hypersensitivity",
                "Fetal distress, polyhydramnios, partial placenta previa, prematurity, borderline cephalopelvic disproportion, previous major surgery of cervix or uterus (incl C-section), overdistension of uterus, grand multiparity, invasive cervical carcinoma, history of uterine sepsis or traumatic delivery",
                "Hyperstimulation of the uterus, with strong (hypertonic) &/or prolonged (tetanic) contractions, or a resting uterine tone of 15-20 mm H2O between contractions may occur, possibly resulting in uterine rupture, cervical & vaginal lacerations, postpartum hemorrhage, abruptio placentae, impaired uterine blood flow, amniotic fluid embolism, & fetal trauma including intracranial hemorrhage",
                "Not indicated for elective labor induction"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "If uterine hyperactivity occurs, discontinue immediately",
                "Intravenous preparations should be be administered by trained personnel",
                "Risk of severe water intoxication on prolonged administration due to its antidiuretic effects",
                "Restricting fluid intake may be warranted",
                "Uterine hypertonicity, spasm, rupture of the uterus, and tetanic contractions may occur from high doses",
                "IM not recommended for labor induction/augmentation"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "fexinidazole",
            "description": {
                "common": "fexinidazole and oxytocin both increase  QTc interval. Avoid or Use Alternate Drug. Avoid coadministration of fexinidazole with drugs known to block potassium channels or prolong QT interval."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "isoflurane",
            "description": {
                "common": "isoflurane and oxytocin both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "lefamulin",
            "description": {
                "common": "lefamulin and oxytocin both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "mefloquine",
            "description": {
                "common": "mefloquine increases toxicity of oxytocin by QTc interval. Avoid or Use Alternate Drug. Mefloquine may enhance the QTc prolonging effect of high risk QTc prolonging agents."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "misoprostol",
            "description": {
                "common": "misoprostol increases effects of oxytocin by pharmacodynamic synergism. Avoid or Use Alternate Drug. Misoprostol may augment the effects  oxytocic agents, especially when given less than 4 hours before initiating oxytocin. ."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "sevoflurane",
            "description": {
                "common": "sevoflurane and oxytocin both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "benzphetamine",
            "description": {
                "common": "oxytocin increases effects of benzphetamine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "carboprost tromethamine",
            "description": {
                "common": "carboprost tromethamine increases effects of oxytocin by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dexfenfluramine",
            "description": {
                "common": "oxytocin increases effects of dexfenfluramine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dexmethylphenidate",
            "description": {
                "common": "oxytocin increases effects of dexmethylphenidate by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dextroamphetamine",
            "description": {
                "common": "oxytocin increases effects of dextroamphetamine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "diethylpropion",
            "description": {
                "common": "oxytocin increases effects of diethylpropion by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dinoprostone",
            "description": {
                "common": "dinoprostone increases effects of oxytocin by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dobutamine",
            "description": {
                "common": "oxytocin increases effects of dobutamine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dopamine",
            "description": {
                "common": "oxytocin increases effects of dopamine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ephedrine",
            "description": {
                "common": "oxytocin increases effects of ephedrine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "epinephrine",
            "description": {
                "common": "oxytocin increases effects of epinephrine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "fenfluramine",
            "description": {
                "common": "oxytocin increases effects of fenfluramine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "fostemsavir",
            "description": {
                "common": "oxytocin and fostemsavir both increase  QTc interval. Use Caution/Monitor. QTc prolongation reported with higher than recommended doses of fostemsavir. "
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "isoproterenol",
            "description": {
                "common": "oxytocin increases effects of isoproterenol by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lisdexamfetamine",
            "description": {
                "common": "oxytocin increases effects of lisdexamfetamine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "methamphetamine",
            "description": {
                "common": "oxytocin increases effects of methamphetamine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "methylenedioxymethamphetamine",
            "description": {
                "common": "oxytocin increases effects of methylenedioxymethamphetamine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "methylphenidate",
            "description": {
                "common": "oxytocin increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "midodrine",
            "description": {
                "common": "oxytocin increases effects of midodrine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "norepinephrine",
            "description": {
                "common": "oxytocin increases effects of norepinephrine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "phendimetrazine",
            "description": {
                "common": "oxytocin increases effects of phendimetrazine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "phentermine",
            "description": {
                "common": "oxytocin increases effects of phentermine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "phenylephrine",
            "description": {
                "common": "oxytocin increases effects of phenylephrine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "phenylephrine PO",
            "description": {
                "common": "oxytocin increases effects of phenylephrine PO by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "propylhexedrine",
            "description": {
                "common": "oxytocin increases effects of propylhexedrine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "pseudoephedrine",
            "description": {
                "common": "oxytocin increases effects of pseudoephedrine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "serdexmethylphenidate/dexmethylphenidate",
            "description": {
                "common": "oxytocin increases effects of serdexmethylphenidate/dexmethylphenidate by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "xylometazoline",
            "description": {
                "common": "oxytocin increases effects of xylometazoline by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "yohimbine",
            "description": {
                "common": "oxytocin increases effects of yohimbine by pharmacodynamic synergism. Use Caution/Monitor."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Sinus bradycardia",
            "percent": "5"
        },
        {
            "name": "tachycardia",
            "percent": null
        },
        {
            "name": "premature ventricular complexes",
            "percent": null
        },
        {
            "name": "other arrhythmias",
            "percent": null
        },
        {
            "name": "Permanent CNS or brain damage",
            "percent": null
        },
        {
            "name": "and death secondary to asphyxia",
            "percent": null
        },
        {
            "name": "Neonatal seizure",
            "percent": null
        },
        {
            "name": "Neonatal jaundice",
            "percent": null
        },
        {
            "name": "Fetal death",
            "percent": null
        },
        {
            "name": "Low Apgar score",
            "percent": null
        },
        {
            "name": "min",
            "percent": null
        },
        {
            "name": "Uteroplacental hypoperfusion",
            "percent": null
        },
        {
            "name": "variable deceleration of fetal heart rate",
            "percent": null
        },
        {
            "name": "Fetal hypoxia",
            "percent": null
        },
        {
            "name": "Perinatal hepatic necrosis",
            "percent": null
        },
        {
            "name": "Fetal hypercapnia",
            "percent": null
        },
        {
            "name": "Severe decreases in maternal systolic",
            "percent": null
        },
        {
            "name": "diastolic blood pressure",
            "percent": null
        },
        {
            "name": "increases in heart rate",
            "percent": null
        },
        {
            "name": "systemic venous return",
            "percent": null
        },
        {
            "name": "cardiac output",
            "percent": null
        },
        {
            "name": "arrhythmia",
            "percent": null
        }
    ]
}